Brian Klepper In this issue’s guest essay, VIVIO Health’s CEO Pramod John guides us through four sensible drug policy changes and supporting rationales that could make drug pricing much fairer. Reading through it, one is struck by the magnitude of the drug manufacturing industry’s influence over policy, profoundly benefiting that sector at the deep expense […]
The move toward high-performance and high-value healthcare
In-depth analysis of the latest trends and solutions that improve heath outcomes, strengthen accountability, and cut costs
Actionable insights on how to drive better health outcomes at a far lower cost for your organization.
Profiles in innovative solutions and organizations that are “walking the walk” when it comes to delivering better savings, outcomes, and more
The move toward high-performance and high-value healthcare
In-depth analysis of the latest trends and solutions that improve heath outcomes, strengthen accountability, and cut costs
Actionable insights on how to drive better health outcomes at a far lower cost for your organization.
Profiles in innovative solutions and organizations that are “walking the walk” when it comes to delivering better savings, outcomes, and more
